References
- 1. T. Kennedy, Managing the drug discovery and development interface, Drug Discov. Today 2 (1997) 436-444; DOI: 10.1016/S1359-6446(97)01099-4.
- 2. M. Brvar, A. Perdih, V. Hodnik, M. Renko, G. Anderluh, R. Jerala and T. Solmajer, In silico discovery and biophysical evaluation of novel 5-(2-hydroxybenzylidene) rhodanine inhibitors of DNA gyrase B, Bioorg. Med. Chem. 20 (2012) 2572-2580; DOI: 10.1016/j.bmc.2012.02.052.
- 3. N. G. Chee, Y. Xiao, W. Putnam, B. Lum and A. Tropsha, Quantitative structure-pharmacokinetic parameters relationships (QSPKR) analysis of antimicrobial agents in humans using simulated annealing k-nearest-neighbor and partial least-square analysis methods, J. Pharm. Sci. 93 (2004) 2535-2544; DOI: 10.1002/jps.20117.
- 4. J. V. Turner, D. J. Maddalena, D. J. Cutler and S. Agatonovic-Kustrin, Multiple pharmacokinetic parameter prediction for a series of cephalosporins, J. Pharm. Sci. 92 (2003) 552-559; DOI: 10.1002/jps.10314.
- 5. R. S. Obach, F. Lombardo and N. J. Waters, Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 compounds, Drug Metab. Dispos. 36 (2008) 1385-1405; DOI: 10.1124/dmd.108.020479.
- 6. World Health Organization Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC classification and DDD assignment 2010, 13th ed., WHO Collaborating Centre for Drug Statistics Methodology, Oslo 2009, pp. 163-177.
- 7. A. Tropsha, P. Gramatica and V. K. Gombar, The importance of being earnest: validation is the absolute essential for successful application and interpretation of QSPR models, QSAR Comb. Sci. 22 (2003) 69-77; DOI: 10.1002/qsar.200390007.
- 8. National Center for Biotechnology Information, PubChem Compound Database; http://pubchem.ncbi.nlm.nih.gov/access January 20, 2011.
- 9. I. V. Tetko, J. Gasteiger, R. Todeschini, A. Mauri, D. Livingstone, P. Ertl, V. A. Palyulin, E. V. Radchenko, N. S. Zefirov, A. S. Makarenko, V. Y. Tanchuk and V. V. J. Prokopenko, Virtual computational chemistry laboratory - design and description, Comput. Aid. Mol. Des. 19 (2005) 453-463; DOI: 10.1007/s10822-005-8694-y.
- 10. M. A. Hall and G. Holmes, Benchmarking attribute selection techniques for discrete class data mining, IEEE Trans. Knowl. Data Eng. 15 (2003) 1437-1447; DOI: 10.1109/TKDE.2003.1245283.
- 11. T. Wajima, K. Fukumura, Y. Yano and T. Oguma, Prediction of human clearance from animal data and molecular structural parameters using multivariate regression analysis, J. Pharm. Sci. 91 (2002) 2489-2499; DOI: 10.1002/jps.10242.
- 12. P. P. Roy, S. Paul, I. Mitra and K. Roy, On two novel parameters for validation of predictive QSAR models, Molecules 14 (2009) 1660-1701; DOI: 10.3390/molecules 15010604.
- 13. J. Zupan and J. Gasteiger, Neural Networks in Chemistry and Drug Design, Wiley-VCH, Weinheim 1999, pp. 125-154.
- 14. H. Li, Y. Liang and Q. Xu, Support vector machines and its applications in chemistry, Chemometr. Intell. Lab. 95 (2009) 188-198; DOI: 10.1016/j.chemolab.2008.10.007.
- 15. S. K. Shevade, S. S. Keerthi, C. Bhattacharyya and K. R. K. Murthy, Improvements to SMO Algorithm for SVM Regression, Technical Report CD-99-16, Control Division, Department of Mechanical and Production Engineering, National University of Singapore, Singapore 1999.
- 16. J. Gasteiger, J. Sadowski, J. Schuur, P. Selzer, L. Steinhauer and V. Steinhauer, Chemical information in 3D space, J. Chem. Inf. Comput. Sci. 36 (1996) 1030-1037; DOI: 10.1021/ci960343.
- 17. M. Petitjean, Applications of the radius-diamater diagram to the classification of topological and geometrical shapes of chemical compounds, J. Chem. Inf. Comput. Sci. 32 (1992) 331-337; DOI: 10.1021/ci00008a012.
- 18. R. S. Obach, J. G. Baxter, T. E. Liston, B. M. Silber, B. C. Jones, F. MacIntyre, D. J. Rance and P. Wastall, The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data, J. Pharmacol Exp. Ther. 283 (1997) 46-58.